Osiris Therapeutics, Inc. To Attend The Brean Capital 2015 Life Sciences Summit

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that it will attend the Brean Capital 2015 Life Sciences Summit on Monday, November 16, 2015. Lode Debrabandere, Ph.D., President and Chief Executive Officer, Gregory Law, Chief Financial Officer and Frank Czworka, Vice President and GM Wound Care are scheduled to participate in one-on-one sessions and group meetings during the Summit at the Millennium Broadway Hotel, New York, NY.

Help employers find you! Check out all the jobs and post your resume.

Back to news